From capability to connectivity — absorptive capacity and exploratory alliances in biopharmaceutical firms: a US–Europe comparison

Tianjiao Xia, S Roper

Research output: Contribution to journalArticlepeer-review

57 Citations (Scopus)

Abstract

In this paper, we explore the relationship between aspects of firms’ potential absorptive capacity (PACAP) on their involvement in exploratory alliances. Our study is based on survey data from firms in the US and European (the UK, Germany, France and Ireland) biopharmaceutical sectors. We use zero inflated negative binomial (ZINB) models to capture the number of exploratory alliances in which firms are engaged, and find that the assimilation dimension of PACAP is significantly more important than the acquisition dimension. More specifically, we find that skill levels and continuous R&D play an important role in determining biopharmaceutical firms’ exploratory alliance activity, while R&D intensity proves relatively unimportant. Our results also highlight differences between the determinants of alliance behaviour in the US and Europe: in the US firms’ skill levels prove more significant, while in Europe continuity of R&D proves more significant. Commonalities are also observed, however, with firms’ strategic focus and an inverted ‘U’ shaped relationship between firm size and alliance engagement evident in both areas.
Original languageEnglish
Pages (from-to)776-785
Number of pages10
JournalTechnovation
Volume28
Issue number11
DOIs
Publication statusPublished - Nov 2008

Fingerprint Dive into the research topics of 'From capability to connectivity — absorptive capacity and exploratory alliances in biopharmaceutical firms: a US–Europe comparison'. Together they form a unique fingerprint.

Cite this